Dashboard
Manage Tickers

HRTX HERON THERAPEUTICS, INC. /DE/

Nasdaq herontx.com


$ 1.29 $ -0.01 (-0.77 %)    

Friday, 17-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.29
$ 1.30
$ 1.27 x 237
$ 1.40 x 1,030
$ 1.28 - $ 1.32
$ 1.04 - $ 2.68
640,734
na
197.75M
$ 1.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-05-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-06-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-19-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heron-therapeutics-files-for-mixed-shelf-of-up-to-125m
Heron Therapeutics Files For Mixed Shelf O...
09/09/2025 21:15:16

-SEC Filing

heron-therapeutics-adopts-section-382-rights-plan-to-protect-nols-and-tax-attributes-plan-approved-by-board-and-satisfies-covenant-under-note-agreement-with-rubric-capital
Heron Therapeutics Adopts Section 382 Righ...
08/15/2025 11:47:15

Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, to...

needham-maintains-buy-on-heron-therapeutics-lowers-price-target-to-3
Needham Maintains Buy on Heron Therapeutic...
08/08/2025 19:01:51

Needham analyst Serge Belanger maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and lowers the price target from $4 to $3.

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/08/2025 17:07:58

heron-therapeutics-affirms-fy2025-sales-guidance-of-153000m-163000m-vs-158538m-est
Heron Therapeutics Affirms FY2025 Sales Gu...
08/08/2025 11:57:41

Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.000 million-$163.000 million to $153.000 million-$163.0...

heron-therapeutics-q2-eps-002-misses-001-estimate-sales-37200m-miss-38075m-estimate
Heron Therapeutics Q2 EPS $(0.02) Misses $...
08/08/2025 11:53:55

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of ...

this-ryder-system-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Ryder System Analyst Begins Coverage ...
06/09/2025 15:23:37

hc-wainwright--co-initiates-coverage-on-heron-therapeutics-with-buy-rating-announces-price-target-of-6
HC Wainwright & Co. Initiates Coverage On ...
06/09/2025 11:29:16

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Heron Therapeutics (NASDAQ:HRTX) with a Buy rating and ...

heron-therapeutics-affirms-fy2025-sales-guidance-of-15300m-16300m-vs-15727m-est
Heron Therapeutics Affirms FY2025 Sales Gu...
05/06/2025 12:09:22

Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.00 million-$163.00 million to $153.00 million-$163.00 m...

heron-therapeutics-q1-eps-001-beats-001-estimate-sales-3890m-beat-3742m-estimate
Heron Therapeutics Q1 EPS $0.01 Beats $(0....
05/06/2025 12:03:31

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(...

heron-therapeutics-enters-settlement-agreement-with-mylan-to-resolve-patent-litigations-in-us-district-court-for-the-district-of-delaware-related-to-cinvanti-and-aponvie
Heron Therapeutics Enters Settlement Agree...
05/06/2025 11:32:59

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

needham-reiterates-buy-on-heron-therapeutics-maintains-4-price-target
Needham Reiterates Buy on Heron Therapeuti...
04/11/2025 10:46:52

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $4 price target.

needham-reiterates-buy-on-heron-therapeutics-maintains-4-price-target
Needham Reiterates Buy on Heron Therapeuti...
02/28/2025 10:14:59

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $4 price target.

heron-therapeutics-expects-2025-sales-of-153m-163m-versus-consensus-of-160633m
Heron Therapeutics Expects 2025 Sales Of $...
02/27/2025 12:48:45

Financial Guidance for 2025 Item2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA(in millions) Net Revenue$153.0 to$1...

heron-therapeutics-q4-2024-gaap-eps-002-beats-003-estimate-sales-4078m-beat-3737m-estimate
Heron Therapeutics Q4 2024 GAAP EPS $0.02 ...
02/27/2025 12:46:24

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(...

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/04/2024 21:06:10

needham-reiterates-buy-on-heron-therapeutics-maintains-4-price-target
Needham Reiterates Buy on Heron Therapeuti...
12/04/2024 11:45:53

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $4 price target.

why-marvell-technology-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Marvell Technology Shares Are Trading ...
12/04/2024 10:11:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION